HTA and P&R agencies have diverse evidence requirements and methodological guidelines that manufacturers need to adhere to in developing HTA/P&R submissions. The 4H PRA™ is an interactive strategic planning tool designed to evaluate the planned and required evidence for your product on a country-by-country basis.
The Payer Readiness Assessment (PRA™) covers the US and major five EU markets (France, Germany, Italy, Spain, and the UK), Netherlands, Sweden, Australia, Canada and Brazil; additional countries can be added.
The Payer Readiness Assessment (PRA™) facilitates:
- Mapping of existing and planned evidence against HTA/P&R requirements in individual markets
- Identification of evidence gaps and prioritization of evidence generation at global and affiliate levels
- Communication between global and affiliate groups on how to bridge evidence gaps to ensure optimal market access
- Evidence generation plan provides detailed descriptions of key work streams linked to the HTA/P&R requirements, to enable scenario analysis and facilitate budget planning